In episode 13, we chat with Ameet Nathwani, CEO at Dewpoint Therapeutics.  Find out why you shouldn’t underestimate the complexity of the biology and the disease as it pertains to global approvals. First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder & guest host Co-Founder, Andrew Brackin.Episodes launch weekly on Tuesdays.To view the full transcript of this episode, click here.Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.